Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study
Massimiliano Buoli, Alice Caldiroli, Gabriele Panza, Alfredo Carlo Altamura
Psychiatry Investig. 2012;9(4):354-360.   Published online 2012 Nov 14     DOI: https://doi.org/10.4306/pi.2012.9.4.354
Comparison between olanzapine and aripiprazole treatment for 104 weeks after hospital discharge in schizophrenia spectrum disorders: a multicenter retrospective cohort study in a real-world setting
Tomonari Hosokawa, Chikara Miyaji, Yusaku Yoshimura, Kenji Washida, Yuji Yada, Shinji Sakamoto, Yuko Okahisa, Soshi Takao, Akira Nomura, Yoshiki Kishi, Toshiki Harada, Manabu Takaki, Toshihiko Takeda, Norihito Yamada
Psychopharmacology.2023; 240(9): 1911.     CrossRef
High Rate of Discontinuation during Long-Acting Injectable Antipsychotic Treatment in Patients with Psychotic Disorders
Anna Maria Auxilia, Massimiliano Buoli, Alice Caldiroli, Greta Silvia Carnevali, Agnese Tringali, Roberto Nava, Massimo Clerici, Enrico Capuzzi
Biomedicines.2023; 11(2): 314.     CrossRef
Novel pharmacotherapy targeting the positive symptoms of schizophrenia
Enrico Capuzzi, Alice Caldiroli, Cecilia Quitadamo, Francesco Butturini, Teresa Surace, Massimo Clerici, Massimiliano Buoli
Expert Opinion on Pharmacotherapy.2023; 24(14): 1623.     CrossRef
Gender differences in clinical and biochemical parameters among patients hospitalized for schizophrenia: towards precision medicine
Cecilia Maria Esposito, Francesca De Cagna, Alice Caldiroli, Enrico Capuzzi, Alessandro Ceresa, Martina Di Paolo, Anna Maria Auxilia, Martina Capellazzi, Ilaria Tagliabue, Luisa Cirella, Massimo Clerici, Natascia Brondino, Jennifer L. Barkin, Pierluigi Po
European Archives of Psychiatry and Clinical Neuroscience.2023;[Epub]     CrossRef
Safety and effectiveness of oral blonanserin for schizophrenia: A review of Japanese post-marketing surveillances
Yoshifumi Inoue, Kimiko Tsuchimori, Hiroshi Nakamura
Journal of Pharmacological Sciences.2021; 145(1): 42.     CrossRef
Serum Progesterone and Testosterone Levels in Schizophrenia Patients at Different Stages of Treatment
Wei Huang, Yong-Hang Li, Shi-Qing Huang, Hui Chen, Zai-Fang Li, Xi-Xi Li, Xue-Song Li, Yong Cheng
Journal of Molecular Neuroscience.2021; 71(6): 1168.     CrossRef
Factors Associated with Cognitive Score in People with Schizophrenia at Prof. Dr. M. Ildrem Mental Hospital Medan
Julius Martin Siagian, Bahagia Loebis, Vita Camellia, Elmeida Effendy
Open Access Macedonian Journal of Medical Sciences.2021; 9(T3): 212.     CrossRef
Trial exclusion criteria and their impact on the estimation of antipsychotic drugs effect: A case study using the SOHO database
Clementine Nordon, Thomas Bovagnet, Mark Belger, Javier Jimenez, Robert Olivares, Helene Chevrou-Severac, Helene Verdoux, Josep Maria Haro, Lucien Abenhaim, Helene Karcher
Schizophrenia Research.2018; 193: 146.     CrossRef
Cognitive correlates of neuroimaging abnormalities in the onset of schizophrenia: A case report
Silvia Grassi, Giulia Orsenigo, Marta Serati, Elisabetta Caletti, Alfredo Carlo Altamura, Massimiliano Buoli
World Journal of Psychiatry.2017; 7(2): 128.     CrossRef
Impaired prefrontal activity to regulate the intrinsic motivation-action link in schizophrenia
Kazuyoshi Takeda, Madoka Matsumoto, Yousuke Ogata, Keiko Maida, Hiroki Murakami, Kou Murayama, Keigo Shimoji, Takashi Hanakawa, Kenji Matsumoto, Kazuyuki Nakagome
NeuroImage: Clinical.2017; 16: 32.     CrossRef
Progesterone: The neglected hormone in schizophrenia? A focus on progesterone-dopamine interactions
Jeehae Sun, Adam J. Walker, Brian Dean, Maarten van den Buuse, Andrea Gogos
Psychoneuroendocrinology.2016; 74: 126.     CrossRef
May selective serotonin reuptake inhibitors (SSRIs) provide some benefit for the treatment of schizophrenia?
Massimiliano Buoli, Marta Serati, Valentina Ciappolino, A. Carlo Altamura
Expert Opinion on Pharmacotherapy.2016; 17(10): 1375.     CrossRef
Psychiatric Conditions in Parkinson Disease
Massimiliano Buoli, Alice Caldiroli, Alfredo Carlo Altamura
Journal of Geriatric Psychiatry and Neurology.2016; 29(2): 72.     CrossRef
Is duration of illness really influencing outcome in major psychoses?
Alfredo Carlo Altamura, Marta Serati, Massimiliano Buoli
Nordic Journal of Psychiatry.2015; 69(6): 1685.     CrossRef
Severity of core symptoms in first episode schizophrenia and long-term remission
Carlo Marchesi, Andrea Affaticati, Alberto Monici, Chiara De Panfilis, Paolo Ossola, Matteo Tonna
Psychiatry Research.2015; 225(1-2): 129.     CrossRef
Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: Comparison with schizophrenia
A. Carlo Altamura, Massimiliano Buoli, Sara Pozzoli
Psychiatry and Clinical Neurosciences.2014; 68(1): 21.     CrossRef
Predictors of symptomatic remission in patients with first-episode schizophrenia: A 16years follow-up study
Carlo Marchesi, Andrea Affaticati, Alberto Monici, Chiara De Panfilis, Paolo Ossola, Matteo Tonna
Comprehensive Psychiatry.2014; 55(4): 778.     CrossRef